中国当代医药
中國噹代醫藥
중국당대의약
China Modern Medicine
2015年
29期
70-72
,共3页
放疗%盐酸羟考酮缓释片%骨转移癌痛
放療%鹽痠羥攷酮緩釋片%骨轉移癌痛
방료%염산간고동완석편%골전이암통
Radiation%Oxycodone hydrochloride sustained-release tablets%Bone metastatic pain
目的:探讨放疗联合盐酸羟考酮缓释片治疗骨转移癌痛的效果。方法选取2014年5月~2015年5月本院肿瘤科收治的42例骨转移癌痛患者作为研究对象,随机分为对照组和观察组,各21例。对照组给予盐酸羟考酮缓释片口服,观察组给予放疗联合盐酸羟考酮缓释片治疗。比较两组的疼痛缓减程度及不良反应发生率。结果观察组治疗2、4、6周后的疼痛缓解程度显著优于对照组,差异有统计学意义(P<0.05)。观察组的生活质量提高所占比例显著优于对照组,差异有统计学意义(P<0.05)。两组的不良反应率比较,差异无统计学意义(P>0.05)。结论采用放疗联合盐酸羟考酮缓释片治疗骨转移,可缓解患者的疼痛程度,值得临床推广应用。
目的:探討放療聯閤鹽痠羥攷酮緩釋片治療骨轉移癌痛的效果。方法選取2014年5月~2015年5月本院腫瘤科收治的42例骨轉移癌痛患者作為研究對象,隨機分為對照組和觀察組,各21例。對照組給予鹽痠羥攷酮緩釋片口服,觀察組給予放療聯閤鹽痠羥攷酮緩釋片治療。比較兩組的疼痛緩減程度及不良反應髮生率。結果觀察組治療2、4、6週後的疼痛緩解程度顯著優于對照組,差異有統計學意義(P<0.05)。觀察組的生活質量提高所佔比例顯著優于對照組,差異有統計學意義(P<0.05)。兩組的不良反應率比較,差異無統計學意義(P>0.05)。結論採用放療聯閤鹽痠羥攷酮緩釋片治療骨轉移,可緩解患者的疼痛程度,值得臨床推廣應用。
목적:탐토방료연합염산간고동완석편치료골전이암통적효과。방법선취2014년5월~2015년5월본원종류과수치적42례골전이암통환자작위연구대상,수궤분위대조조화관찰조,각21례。대조조급여염산간고동완석편구복,관찰조급여방료연합염산간고동완석편치료。비교량조적동통완감정도급불량반응발생솔。결과관찰조치료2、4、6주후적동통완해정도현저우우대조조,차이유통계학의의(P<0.05)。관찰조적생활질량제고소점비례현저우우대조조,차이유통계학의의(P<0.05)。량조적불량반응솔비교,차이무통계학의의(P>0.05)。결론채용방료연합염산간고동완석편치료골전이,가완해환자적동통정도,치득림상추엄응용。
Objective To explore the effect of radiotherapy combined with oxycodone hydrochloride sustained-release tablet in the treatment of bone metastatic pain. Methods 42 patients with bone metastatic pain treated in oncology de-partment of our hospital from May 2014 to May 2015 were selected and randomly divided into the control group and the observational group,21 cases in each group.The control group was treated with oral oxycodone hydrochloride sus-tained-release tablet,the observational group was treated with radiology combined with oxycodone hydrochloride sus-tained-release tablet.The degree of pain relief and the incidence rate of adverse reaction in two groups was compared respectively. Results The degree of pain relief after treatment in 2,4,6 weeks in the observation group was better than that in the control group,with significant difference (P<0.05).The proportion of life quality improvement in the observa-tion group was better than that in the control group,with significant difference (P<0.05).There was no significant differ-ence in the incidence of adverse reaction in two groups (P>0.05). Conclusion The application of radiation combined with oxycodone hydrochloride sustained-release tablets in the treatment of bone metastatic pain can relievepain of pa-tients,it is worthy of promotion and application.